CSS
ZYME icon

Cubist Systematic Strategies’s Zymeworks ZYME Stock Holding History

Cubist Systematic Strategies’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-119,962
Closed -$1.51M – 3658
2025
Q2 		$1.51M Buy
+119,962
New +$1.43M 0.01% 1713
2024
Q1 		– Sell
-18,170
Closed -$189K – 4356
2023
Q4 		$189K Buy
+18,170
New +$145K ﹤0.01% 3026
2023
Q3 		– Sell
-3,225
Closed -$27.9K – 4017
2023
Q2 		$27.9K Sell
3,225
-292,682
-99% -$2.62M ﹤0.01% 3156
2023
Q1 		$2.67M Buy
295,907
+241,177
+441% +$2.1M 0.02% 1433
2022
Q4 		$430K Buy
54,730
+46,206
+542% +$325K ﹤0.01% 3124
2022
Q3 		$52K Sell
8,524
-221,266
-96% -$1.33M ﹤0.01% 4126
2022
Q2 		$1.22M Buy
229,790
+214,270
+1,381% +$1.3M 0.01% 2311
2022
Q1 		$102K Sell
15,520
-29,103
-65% -$259K ﹤0.01% 3239
2021
Q4 		$731K Buy
44,623
+36,029
+419% +$751K 0.01% 2160
2021
Q3 		$250K Buy
8,594
+7,537
+713% +$251K ﹤0.01% 2461
2021
Q2 		$37K Sell
1,057
-38,273
-97% -$1.21M ﹤0.01% 2815
2021
Q1 		$1.24M Buy
39,330
+3,960
+11% +$161K 0.02% 1389
2020
Q4 		$1.67M Buy
35,370
+34,165
+2,835% +$1.59M 0.02% 1067
2020
Q3 		$56K Buy
+1,205
New +$41.4K ﹤0.01% 2357
2020
Q2 		– Sell
-499
Closed -$18K – 2548
2020
Q1 		$18K Sell
499
-17,762
-97% -$727K ﹤0.01% 2070
2019
Q4 		$830K Buy
+18,261
New +$664K 0.02% 1275
2019
Q3 		– Sell
-10,040
Closed -$221K – 2526
2019
Q2 		$221K Buy
10,040
+742
+8% +$13.6K ﹤0.01% 2005
2019
Q1 		$151K Sell
9,298
-265
-3% -$4.11K ﹤0.01% 1894
2018
Q4 		$140K Sell
9,563
-1,281
-12% -$16.8K 0.01% 1667
2018
Q3 		$170K Buy
10,844
+4,000
+58% +$57.2K 0.01% 1463
2018
Q2 		$101K Buy
+6,844
New +$106K 0.01% 1536

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Cubist Systematic Strategies's ZYME Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Zymeworks (ZYME) in Q3 2025, closing a stake of 119,962 shares — an estimated $1.51M sold.

Cubist Systematic Strategies first reported a position in ZYME in Q2 2018 and held it in 21 quarters. The position peaked at $2.67M in Q1 2023. 183 funds tracked by Wall St. Rank hold ZYME as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Zymeworks position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 119,962 Zymeworks shares in Q3 2025, an estimated $1.51M.
  • Cubist Systematic Strategies first reported a position in Zymeworks in Q2 2018 and held it in 21 quarters.
  • Cubist Systematic Strategies's Zymeworks position peaked at $2.67M in Q1 2023.
  • 183 funds tracked by Wall St. Rank held Zymeworks as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.